NAION AND ANTICOAGULANTS: BRIDGING THE GAP WITH RATIONALE-BASED THERAPY

Authors

  • Syntia Nusanti Doctoral Program in Medical Science, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia and Neuro-ophthalmology Division, Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Andhika Rachman Hematology and Medical Oncology Division, Department of Internal Medicine, Faculty of Medicine University of Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
  • Brigitta Marcia Budihardja Residency Program in Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Lourisa Ruth Eldinia Research Assistant, Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Nadia Delima Andini Research Assistant, Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Arief Kartasasmita Vitreoretina Division, Ophthalmology Department, Faculty of Medicine Padjajaran University – Cicendo Eye Hospital, Bandung, Indonesia
  • Sidik M. Neuro-ophthalmology Division, Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Seskoati Prayitnaningsih Neuro-ophthalmology Division, Ophthalmology Department, Faculty of MedicineBrawijaya University – Saiful Anwar General Hospital, Malang, Indonesia
  • Alida Roswita Harahap Doctoral Program in Medical Science, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • Aria Kekalih Community Medicine Department, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • Tjahjono Darminto Gondhowiardjo Cataract and Refractive Surgery Division, Ophthalmology Department, Faculty of Medicine University of Indonesia – Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

DOI:

https://doi.org/10.55519/JAMC-02-12644

Keywords:

non-arteritic anterior ischemic optic neuropathy, anticoagulant, optical coherence tomography angiography, visual field, visual acuity, thrombophilia

Abstract

Background: NAION, a multifactorial disorder with an unclear mechanism has limited insight on its treatment option. Despite conflicting results in its relation to hypercoagulation, many metabolic risk factors associated with NAION are intertwined with hypercoagulation. We aim to investigate the impact of anticoagulant therapy in the vascular and visual function of NAION patients. Methods: A prospective interventional study was conducted in the Neuro-Ophthalmology Division, Department of Ophthalmology at FKUI-RSCM Kirana from October 2020 to April 2022, involving two groups of NAION subjects: hypercoagulation and non-hypercoagulation. All subjects received 80 mg of aspirin daily, with the hypercoagulation group additionally receiving 2 mg of warfarin. We assessed capillary perfusion (CP) and flux index (FI) using OCTA, along with changes in visual acuity (Snellen chart test) and visual field (Humphrey Visual Field - HVF) at presentation and one month after treatment. Results: The hypercoagulation group had 14 subjects, while the non-hypercoagulation group had 7. This research found a significant decrease for CP (p=0.003) and FI (p=0.001) in both groups. CP and FI in all quadrants decreased more in the non-hypercoagulable group without anticoagulant therapy, although the difference between the two groups was not significant (p=0.198 for CP and p=0.243 for FI). Hypercoagulation group showed significant visual field improvements (p=0.033 for MD and p=0.014 for VFI). Most subjects within hypercoagulation showed improvement although not all of it was significant, while the majority of the non-hypercoagulation group showed no changes. 

References

Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. 2015 [cited 2023 Oct 20]; Available from: www.nature.com/eye

Subekti I, Soewondo P, Soebardi S, Darmowidjojo B, Harbuwono DS, Purnamasari D, et al. Practical Guidelines Management of Graves Ophthalmopathy [Internet]. Vol. 51, Acta Med Indones-Indones J Intern Med •. 2019. Available from: www.actamedindones.org/index.php/ijim/

Aftab AM, Iqbal M, Rauf A, Ali A. The Ayub Med College Abbottabad. 2016 [cited 2023 Oct 29]. p. 776–80 View of Non Arteritic Anterior Ischemic Optic Neuropathy; Does Anticoagulation Help? Available from: https://jamc.ayubmed.edu.pk/jamc/index.php/jamc/article/view/111/734

Kerr NM, Chew SSSL, Danesh-Meyer H V. Non-arteritic anterior ischaemic optic neuropathy: A review and update. Journal of Clinical Neuroscience [Internet]. 2009 Aug 1 [cited 2023 Oct 29];16(8):994–1000. Available from: http://www.jocn-journal.com/article/S0967586809002070/fulltext

Lee SH, Lee WH, Lim H Bin, Jo YJ, Kim JY. Thicknesses of central macular, retinal nerve fiber, and ganglion cell inner plexiform layers in patients with hypertension. Retina [Internet]. 2019 Sep 1 [cited 2023 Oct 29];39(9):1810–8. Available from: https://journals.lww.com/retinajournal/fulltext/2019/09000/thicknesses_of_central_macular,_retinal_nerve.21.aspx

Nagy V, Kolozsvari B, Balogh Z, Csutak A, Kasza M, Nagy B, et al. Increased level of platelet P-selectin in nonarteritic anterior ischemic optic neuropathy.

Mohan JS, Lip GYH, Wright J, Bareford D, Blann AD. Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation. Blood Coagul Fibrinolysis [Internet]. 2005 [cited 2023 Oct 20];16(3):209–14. Available from: https://pubmed.ncbi.nlm.nih.gov/15795541/

Nakashima MO, Rogers HJ. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res [Internet]. 2014 [cited 2023 Oct 20];49(2):85. Available from: /pmc/articles/PMC4090343/

Citirak G, Malmqvist L, Hamann S. Analysis of Systemic Risk Factors and Post-Insult Visual Development in a Danish Cohort of Patients with Nonarteritic Anterior Ischemic Optic Neuropathy. 2022 [cited 2023 Oct 29]; Available from: https://doi.org/10.2147/OPTH.S384740

Rebolleda G, Diéz-Álvarez L, Garciá Marín Y, De Juan V, Munõz-Negrete FJ. Reduction of Peripapillary Vessel Density by Optical Coherence Tomography Angiography from the Acute to the Atrophic Stage in Non-Arteritic Anterior Ischaemic Optic Neuropathy. Ophthalmologica [Internet]. 2018 Nov 29 [cited 2023 Oct 29];240(4):191–9. Available from: https://dx.doi.org/10.1159/000489226

Fard MA, Suwan Y, Moghimi S, Geyman LS, Chui TY, Rosen RB, et al. Pattern of peripapillary capillary density loss in ischemic optic neuropathy compared to that in primary open-angle glaucoma. PLoS One. 2018 Jan 1;13(1).

Huang HM, Wu PC, Kuo HK, Chen YJ, Poon LYC. Natural history and visual outcome of nonarteritic anterior ischemic optic neuropathy in Southern Taiwan: a pilot study. Int Ophthalmol. 2020 Oct 1;40(10):2667–76.

Downloads

Published

2024-06-30